Overall, it is tempting to speculate that, like in the haematopoietic system, absence of TET2 activity, either by IDH1/2 mutations or by promoter methylation, promotes self-renewal of tumour-initiating cells for low-grade diffuse gliomas. Here, IDH1 is linked to neoplasm.